Education
About Us
Working with TipRanks
Follow Us
Bioline RX Ltd Sponsored ADR (BLRX)
NASDAQ:BLRX
RESEARCH TOOLSreports
Total Valuation
Bioline RX Ltd Sponsored ADR has a market cap or net worth of $10.43M. The enterprise value is $13.66M.
Market Cap$10.43M
Enterprise Value$13.66M
Share Statistics
Bioline RX Ltd Sponsored ADR has 3,721,003 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,721,003
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bioline RX Ltd Sponsored ADR’s return on equity (ROE) is -4.58 and return on invested capital (ROIC) is -135.24%.
Return on Equity (ROE)-4.58
Return on Assets (ROA)-0.95
Return on Invested Capital (ROIC)-135.24%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee171.43K
Profits Per Employee-2.16M
Employee Count28
Asset Turnover0.08
Inventory Turnover1.89
Valuation Ratios
The current PE Ratio of Bioline RX Ltd Sponsored ADR is -66.54. Bioline RX Ltd Sponsored ADR’s PEG ratio is -0.43.
PE Ratio-66.54
PS Ratio2.65
PB Ratio305.02
Price to Fair Value305.02
Price to FCF-176.09
Price to Operating Cash Flow-178.40
PEG Ratio-0.43
Income Statement
In the last 12 months, Bioline RX Ltd Sponsored ADR had revenue of 4.80M and earned -60.61M in profits. Earnings per share was -0.06.
Revenue4.80M
Gross Profit1.11M
Operating Income-49.69M
Pretax Income-60.61M
Net Income-60.61M
EBITDA-57.06M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was -30.27M and capital expenditures -77.00K, giving a free cash flow of -30.35M billion.
Operating Cash Flow-30.27M
Free Cash Flow-30.35M
Free Cash Flow per Share-8.16
Dividends & Yields
Bioline RX Ltd Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.47
52-Week Price Change-86.96%
50-Day Moving Average3.18
200-Day Moving Average14.51
Relative Strength Index (RSI)50.33
Average Volume (3m)27.68K
Important Dates
Bioline RX Ltd Sponsored ADR upcoming earnings date is May 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 21, 2025
Ex-Dividend Date―
Financial Position
Bioline RX Ltd Sponsored ADR as a current ratio of 1.53, with Debt / Equity ratio of 348.20%
Current Ratio1.53
Quick Ratio1.47
Debt to Market Cap<0.01
Net Debt to EBITDA-0.13
Interest Coverage Ratio-22.91
Taxes
In the past 12 months, Bioline RX Ltd Sponsored ADR has paid 1.00K in taxes.
Income Tax1.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Bioline RX Ltd Sponsored ADR EV to EBITDA ratio is -1.06K, with an EV/FCF ratio of -2.64K.
EV to Sales12.61K
EV to EBITDA-1.06K
EV to Free Cash Flow-2.64K
EV to Operating Cash Flow-2.68K
Balance Sheet
Bioline RX Ltd Sponsored ADR has $29.17M in cash and marketable securities with $109.56K in debt, giving a net cash position of $441.00K billion.
Cash & Marketable Securities$29.17M
Total Debt$109.56K
Net Cash$441.00K
Net Cash Per Share$0.12
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 68.78%, with operating margin of -1035.29%, and net profit margin of -1262.79%.
Gross Margin68.78%
Operating Margin-1035.29%
Pretax Margin-1262.79%
Net Profit Margin-1262.79%
EBITDA Margin-1188.77%
EBIT Margin-1217.60%
Analyst Forecast
The average price target for Bioline RX Ltd Sponsored ADR is $26.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$26.00
Price Target Upside766.67% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast502.92%
EPS Growth Forecast88.01%